Abstract
New technological concepts have been evolving to manage the relative poor prognosis of lung cancer. Brachytherapy is becoming an option for both unresectable and early resectable lung cancer. Three-dimensional ultrasound (US) of lung tumours and image-guided minimally invasive robotics-assisted brachytherapy are feasible for dosimetry planning and management of lung tumours. The present article reviews the current knowledge of lung brachytherapy and discusses its potential in future management of lung cancer.
Keywords: Brachytherapy, lung tumour, minimally invasive, robotics-assisted surgery and therapy, lung cancer, Endobronchial Brachytherapy, HDR Brachytherapy, Interstitial Brachytherapy, LDR Brachytherapy
Current Respiratory Medicine Reviews
Title: Lung Cancer Brachytherapy: Robotics-Assisted Minimally Invasive Approach
Volume: 7 Issue: 5
Author(s): Edward Yu, Craig Lewis, Ana Luisa Trejos, Rajni V. Patel and Richard A. Malthaner
Affiliation:
Keywords: Brachytherapy, lung tumour, minimally invasive, robotics-assisted surgery and therapy, lung cancer, Endobronchial Brachytherapy, HDR Brachytherapy, Interstitial Brachytherapy, LDR Brachytherapy
Abstract: New technological concepts have been evolving to manage the relative poor prognosis of lung cancer. Brachytherapy is becoming an option for both unresectable and early resectable lung cancer. Three-dimensional ultrasound (US) of lung tumours and image-guided minimally invasive robotics-assisted brachytherapy are feasible for dosimetry planning and management of lung tumours. The present article reviews the current knowledge of lung brachytherapy and discusses its potential in future management of lung cancer.
Export Options
About this article
Cite this article as:
Yu Edward, Lewis Craig, Luisa Trejos Ana, V. Patel Rajni and A. Malthaner Richard, Lung Cancer Brachytherapy: Robotics-Assisted Minimally Invasive Approach, Current Respiratory Medicine Reviews 2011; 7 (5) . https://dx.doi.org/10.2174/157339811797189803
DOI https://dx.doi.org/10.2174/157339811797189803 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Tumor Markers in Patients with Benign and Malignant Pulmonary Diseases; Competitive Evaluation of ProGRP, NSE and Cyfra 21-1
Recent Patents on Biomarkers Streamlined In Vivo Selection and Screening of Human Prostate Carcinoma Avid Phage Particles for Development of Peptide Based In Vivo Tumor Imaging Agents
Combinatorial Chemistry & High Throughput Screening Natural Products from Cyanobacteria with Antimicrobial and Antitumor Activity
Current Pharmaceutical Biotechnology Tumor Stem Cell Niches: A New Functional Framework for the Action of Anticancer Drugs
Recent Patents on Anti-Cancer Drug Discovery Research Progress on the Mechanisms of Combined Bevacizumab and Radiotherapy
Recent Patents on Anti-Cancer Drug Discovery Is there a Place for Bevacizumab in Patients with Extensive-Stage Small Cell Lung Cancer?
Current Cancer Drug Targets Paullones as Inhibitors of Protein Kinases
Current Topics in Medicinal Chemistry NF-κB Signaling and Carcinogenesis
Current Pharmaceutical Design Peptide Phage Display: Opportunities for Development of Personalized Anti-Cancer Strategies
Anti-Cancer Agents in Medicinal Chemistry Peptide-Based Anticancer Vaccines: Recent Advances and Future Perspectives
Current Medicinal Chemistry Optimization of Solid Lipid Nanoparticles and Nanostructured Lipidic Carriers as Promising Delivery for Gefitinib: Characterization and Invitro Evaluation
Current Drug Therapy Anti-nociceptive and Anti-inflammatory Activity of Synthesized Novel Benzoxazole Derivatives
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Evaluation of the Anticancer Activities of the Plant Alkaloids Sanguinarine and Chelerythrine in Human Breast Adenocarcinoma Cells
Anti-Cancer Agents in Medicinal Chemistry How Recent Advances in High-risk Myelodysplastic Syndrome Physiopathology May Impact Future Treatments
Current Pharmaceutical Design Molecular Modeling of Peptide Derivatives NS3 Protease Inhibitors of the Type 2 Dengue Virus
Current Physical Chemistry Aspirin as a Chemoprevention Agent for Colorectal Cancer
Current Drug Metabolism Synthesis and Biological Evaluations of Organoruthenium Scaffolds: A Comprehensive Update
Current Organic Synthesis Hypoxia-Inducible Factor 1 in Tumor Radioresistance
Current Signal Transduction Therapy Targeting IAPs as An Approach to Anti-Cancer Therapy
Current Topics in Medicinal Chemistry Molecular Pathways Linking Inflammation and Cancer
Current Molecular Medicine